Cantitate/Preț
Produs

Multiple Myeloma: Recent Results in Cancer Research, cartea 183

Editat de Thomas Moehler, Hartmut Goldschmidt
en Limba Engleză Paperback – 30 mai 2013
Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy, including in particular the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 76628 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 30 mai 2013 76628 lei  6-8 săpt.
Hardback (1) 108159 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 22 apr 2011 108159 lei  6-8 săpt.

Din seria Recent Results in Cancer Research

Preț: 76628 lei

Preț vechi: 80661 lei
-5% Nou

Puncte Express: 1149

Preț estimativ în valută:
14665 15233$ 12181£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642267994
ISBN-10: 3642267998
Pagini: 364
Ilustrații: XXIV, 340 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.5 kg
Ediția:2011
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Recent Results in Cancer Research

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Professional/practitioner

Cuprins

History and epidemiology.- Pathophysiology: Molecular biology of plasma cell disorders. Alterations in microenvironment.- Clinical Features: Imaging. Integrated innovative approach for diagnosis and staging.- Therapy: High-dose chemotherapy and ABSCT.- Allogeneic transplantation. Novel Drugs.- Immunotherapeutic approaches.- First-line treatment and maintenance.- Relapse.- Radiotherapy.- Kyphoplasty.- Supportive Therapy.- Appendix: Staging and prognosis systems.

Textul de pe ultima copertă

Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide means that multiple myeloma now stands at the forefront of advances in oncology drug development. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life.

Caracteristici

Provides detailed up-to-date information on the full range of treatment strategies for multiple myeloma, with due attention to individualized therapy and supportive options Also discusses history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems Written by acknowledged experts Includes supplementary material: sn.pub/extras